About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 294 record(s)
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2020-00024
(i) The total number of Parole Board of Canada decisions made between March 2019 and September 1,2019. (ii) The total number of Parole Board of Canada decisions made between March 2020 and September 1,2020. (iii)The number of Parole Board of Canada decisions made each week between March 1,2019 and September 1,2019. (iv) The number of Parole Board of Canada decisions made each week between March 1,2020 and September 1,2020. (v) The number of Parole Board of Canada decisions made since March 2020,where an offender was granted parole to an "other location" as defined in s.99 (1) of the Corrections and Conditional Release Act.(Further defined in s.4.1 of the Terminology Section of the Decision-Making Policy Manual for Board Members)Organization: Parole Board of Canada
October 2020
Req # A-2020-0026
(1) The number of lifers, on their first parole hearing, who have been granted day parole since Jan 1/2016. (ii) The number of lifers, on their first parole hearing, who have been granted full parole since Jan1/2016. (iii) The number of lifers, by month, granted day parole since Sept 1/2019.(iv)The number of lifers, by month, granted full parole since Sept 1/2019.Organization: Parole Board of Canada
October 2020
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2020-00019
Per the Criminal Records Act, PBC reviews record suspension applications, investigates and makes decisions about granting record suspensions to Canadians who have convictions. Beyond the majority of such convictions, the Criminal Records Act lists specific offences-current and historical-in two Schedules to the Act (Schedule 1 and Schedule 2). Since March 13th,2012 individuals seeking record suspensions for Schedule 1 offences became ineligible unless exception criteria in the Act are met. Schedule 2 offence convictions may still be granted a record suspension the offence did not involve a child. Since 2012 and up to the present, by year, how many record suspensions for :1 )Excepted Schedule 1 convictions and 2) Schedule 2 convictions have been granted by the PBC? This information is requested in aggregate in the format of PBC's choosing but readable as a .pdf or excel document (examples) as derived from its records.Organization: Parole Board of Canada
September 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-00017
All ProServices contracts issued in the National Capital Region for the months of April 2020,May 2020,& June 2020.Please provide copies of contracts and callups.Organization: Parole Board of Canada
August 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020